Complete results of the first randomized, placebo-controlled study of bosentan, a dual endothelin receptor antagonist, in pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Complete results of the first randomized, placebo-controlled study of bosentan, a dual endothelin receptor antagonist, in pulmonary arterial hypertension

Published:2002-04 Issue:4 Volume:63 Page:227-246
ISSN:0011-393X
Container-title:Current Therapeutic Research
language:en
Short-container-title:Current Therapeutic Research

Author:

Badesch David B.,Bodin Frédéric,Channick Richard N.,Frost Adaani,Rainisio Maurizio,Robbins Ivan M.,Roux Sébastien,Rubin Lewis J.,Simonneau Gérald,Sitbon Olivier,Tapson Victor F.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference45 articles.

1. Primary pulmonary hypertension;Rubin;N Engl J Med,1997

2. Diagnosis and treatment of pulmonary hypertension associated with collagen diseases;Kunieda;Intern Med,2000

3. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects;Rosenzweig;Circulation,1999

4. Appetite-suppressant drugs and the risk of primary pulmonary hypertension;Abenhaim;N Engl J Med,1996

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future Perspectives of Pulmonary Arterial Hypertension: A Review of Novel Pipeline Treatments and Indications;Drugs in R&D;2024-03

2. Contribution of pressure and flow changes to resistance reduction after pulmonary arterial hypertension treatment: a meta-analysis of 3898 patients;ERJ Open Research;2023-12-07

3. Medications for the treatment of pulmonary arterial hypertension: a systematic review and network meta-analysis;European Respiratory Review;2022-08-10

4. Efficacy of Commonly Targeted Drugs versus Pulmonary Artery Denervation for Pulmonary Hypertension: A Systematic Review;Advances in Clinical Medicine;2022

5. The Influence of Bosentan on MicroRNA-27a/PPARγ/ET-1 Signaling Pathway in Pulmonary Artery Hypertension;Pediatric Cardiology;2021-04-15